Vertex Pharmaceuticals

IRS: 43039129
VRTX
Vertex Pharmaceuticals

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases.

Founded
1989 (31 years)
CEO
Jeffrey M. Leiden
Investor RelationsSEC
Revenue
4 billion (2019)

Want to see more? Sign up!